Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2015-10-23 Earnings Release
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Trading Update
Earnings Release Classification · 99% confidence The document is titled 'Trading Update' and provides unaudited financial performance highlights for the first quarter (ending September 30, 2015). It details revenue increases, segment performance, pipeline updates, and recent acquisition activity (Genera). This structure—a brief, periodic update on financial results and key business events—aligns best with an Earnings Release (ER). Although it mentions the AGM is happening 'today', the primary content is the trading performance summary, not AGM materials or voting results. It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the initial announcement of the period's results. Q1 2016
2015-10-23 English
Trading update
AGM Information Classification · 95% confidence The document is explicitly titled a "Trading Update" and covers the period from July 1, 2015, to September 30, 2015 (Q1). It provides unaudited financial highlights (revenue growth percentages) and operational updates (pipeline delivery, acquisitions). This structure—a brief, periodic update on performance before the full quarterly report—aligns best with an Earnings Release (ER), which typically contains key highlights. Although it mentions the AGM is happening 'today', the primary content is the trading performance summary, not AGM materials or voting results. It is too detailed for a simple RPA, and it is not the comprehensive quarterly report (IR) or the annual report (10-K).
2015-10-23 English
Acquisition of Genera d.d.
M&A Activity Classification · 98% confidence The document is marked with an 'RNS Number' and begins with 'NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION...'. The content explicitly announces the 'Closing of the Takeover Offer' for Genera d.d. and the subsequent completion of the acquisition, resulting in Dechra owning 92.26% of Genera. This is a significant corporate action related to a merger or takeover. The most appropriate category for an announcement detailing the completion of a takeover bid is 'M&A Activity' (TAR). Although it is distributed via RNS, the specific subject matter points strongly to TAR over the general RNS fallback.
2015-10-21 English
Director/PDMR Shareholding
Major Shareholding Notification Classification · 99% confidence The document is very short (1550 characters) and begins with an 'RNS Number' (9871A), indicating it is a regulatory announcement from the London Stock Exchange's RNS service. The content explicitly states that the Company was notified of a change in the total beneficial interest of an individual (Ian Page) in the Company's shares. This type of filing, reporting personal share transactions by directors or executives, directly matches the definition for Director's Dealing (DIRS). Although it is an RNS announcement, the specific content points strongly to DIRS, which takes precedence over the general RNS fallback.
2015-10-01 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number : 8803A' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content explicitly states the total number of ordinary shares with voting rights (87,982,144) for the purpose of shareholder notification under Disclosure and Transparency Rules (DTR 5.6.1R). This type of mandatory notification regarding share capital structure and voting rights, distributed via the RNS service, fits best under the general 'Regulatory Filings' category (RNS), as there is no specific code for 'Total Voting Rights Notification'. It is not an earnings release, a major shareholding notification (MRQ, which concerns changes in ownership thresholds), or a capital change announcement (SHA, which usually involves issuance/splits). Given the source (RNS) and the nature of the mandatory disclosure, RNS is the most appropriate classification.
2015-10-01 English
Director Declaration
Board/Management Information Classification · 98% confidence The document is very short (761 characters) and announces a change in the board of directors: 'Dr. Christopher Richards a non-executive director of Dechra will be appointed to the Board of Origin Enterprises Plc'. This directly corresponds to the definition of Board/Management Information (MANG). Although it uses the RNS numbering system, the content is specific enough to classify it as MANG rather than the general RNS fallback.
2015-09-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.